Clinical Trial Update: A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics [Phase 1]

View source ↗

Summary

This report covers the completion of a Phase I study evaluating tolerance and pharmacokinetics of the investigational agent TQB3616 in patients with advanced br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TQB3616

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 1 | Status: COMPLETED